Literature DB >> 34797614

Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform.

James C Robinson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34797614     DOI： 10.1056/NEJMp2113679

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Payer-negotiated pricing of the hypoglossal nerve stimulator.

Authors:  Ryan A Bartholomew; Mario V Russo; Roy Xiao; Vinay K Rathi; Afash Haleem; Phillip A Huyett
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

2.  Expedited regulatory product approval in the time of COVID-19.

Authors:  Gary D Novack
Journal:  Ocul Surf       Date:  2022-05-28       Impact factor: 6.268

3.  A Proposal to Increase Value and Equity in the Development and Distribution of New Pharmaceuticals.

Authors:  Paul Sorum; Christopher Stein; Danielle Wales; David Pratt
Journal:  Int J Health Serv       Date:  2022-05-12       Impact factor: 1.851
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.